Lauko, A., Kotecha, R., Barnett, A., Li, H., Tatineni, V., Ali, A., . . . Ahluwalia, M. S. (2021). Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases. Nature Portfolio.
Cita Chicago Style (17a ed.)Lauko, Adam, et al. Impact of KRAS Mutation Status on the Efficacy of Immunotherapy in Lung Cancer Brain Metastases. Nature Portfolio, 2021.
Cita MLA (8a ed.)Lauko, Adam, et al. Impact of KRAS Mutation Status on the Efficacy of Immunotherapy in Lung Cancer Brain Metastases. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.